Medical Countermeasures UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences FundGlobal Biodefense StaffSeptember 29, 2025
Contracts + Grants U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure ContractsGlobal Biodefense StaffSeptember 23, 2025
Pathogens New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum AntiviralsGlobal Biodefense StaffSeptember 23, 2025
Tulane National Primate Research Center Launches Coronavirus Research Program Medical Countermeasures February 21, 2020 …
Columbia University Researchers Awarded $2M to Identify Antiviral Drugs for Coronavirus Medical Countermeasures February 21, 2020 …
Columbia University Researchers Awarded $2 Million to Identify Antiviral Drugs for New Coronavirus Medical Countermeasures February 20, 2020 …
Synedgen to Present Data on Therapeutic for Ocular Mustard Gas Injury at NIH Meeting CBRNE February 19, 2020 …
Humanetics Corporation Acquires Manufacturing Assets for Radioprotectant Drug CBRNE February 19, 2020 …
NIH Study Supports New Approach for Treating Cerebral Malaria Infectious Diseases February 19, 2020 …
HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine Medical Countermeasures February 18, 2020 …
J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics Medical Countermeasures February 18, 2020 …
Atomic Structures Mapped for First Time in Paramyxoviruses Medical Countermeasures February 17, 2020 …
FDA Grants Soligenix “Fast Track” Designation for RiVax® in the Prevention of Ricin Poisoning Medical Countermeasures February 16, 2020 …
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses Medical Countermeasures February 15, 2020 …
Scientists Test Drugs Against Virus Samples from First U.S. COVID-19 Patient Medical Countermeasures February 15, 2020 …
China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19 Medical Countermeasures February 15, 2020 …
Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of SARS-CoV-2 Medical Countermeasures February 12, 2020 …
Insilico Medicine Publishes Molecular Structures for Key Protein Target of SARS-CoV-2 Medical Countermeasures February 6, 2020 …
HHS, Regeneron Collaborate to Develop COVID-19 Treatment Using VelociSuite Technology Medical Countermeasures February 4, 2020 …
